Abstract
Methionine metabolism impairment in human liver disease has been related with an alteration in SAM-synthetase. This deficiency is produced by a post-translational event since human liver cirrhosis presents normal levels of SAM-synthetase mRNA in spite of a more than 50% diminution in its activity. A series of different experiments on the structure and activity of this enzyme have provided strong evidence that SAM-synthetase is regulated by reduced/oxidized glutathione ratio. Restoration of glutathione levels by the addition of S-adenosyl-methionine or glutathione esters in various experimental conditions (buthionine sulfoximine and carbon tetrachloride intoxication) resulted in a normalization of the SAM-synthetase diminution caused by the toxics and an attenuation of the morfological alteration produced in the liver, including fiber production. This findings might have pharmacological implications in the treatment of liver diseases, since the possible beneficial effect of long term administration of SAM could include a reduction of fiber production.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Horowitz, J.H.; Rypins, E.B.; Henderson, J.M.; Heymsfield, S.B.; Moffitt, S.D.; Hain, R.P.; Chaela, R.K. et al.: Evidence for impairment of transsulfuration pathway in cirrhosis. Gastroenterology 1981; 81:668–675.
Kinsell, L.W.; Harper, H.A.; Maton, H.C.; Michael G.D.; Weiss, H.A.: Rate of dissappearance from plasma of intravenously administered methionine in patients with liver damage. Science 1947; 106:589–590.
Martin Duce, A.; Ortiz, P.; Cabrero, C.; Mato, J.M.: S-Adenosyl-L-Methionine synthetase and phospholipid methyltransferase are inhibited in human cirrhosis. Hepatology 1988; 8 (1):65–68.
Rudman, D.; Kutner, M.; Ausley, J.; Jansen, R.; Chipponi, J. et al.: Hypotyrosinemia,hypocistinemia and failute to retain nitrogen during total parenteral nutrition of cirrhotic patients. Gastroenterology 1981, 81:1025–1035.
Marchesini, G.; Bugianesi, E.; Bianchi, G.; Fabbri, A.; Marchi, E.; Zoli, M.; Pisi, E.: Impaired methionine elimination from plasma of patients with liver cirrhosis. Hepatology 1992, 16:149– 155.
Cabrero, C.; Alemany, S.: Conversion of rat liver S-adenosyl-methionine synthetase from high Mr to low-Mr from by LiBr. Biochem. Biophys. Acta 1988; 952:277–281.
Alvarez, L; Asuncion, M; Corrales, F; Pajares, M.A; Mato, J.M. Analysis of the 5’ non-coding region of rat liver SAM-synthetase mRNA and comparison of the Mr deduced from the cDNA sequence and the purified enzyme. FEBS Lett 1991; 290:142–146.
Alvarez, L; Asuncion, M; Martin-Duce, A; Mato,J.M. Characterization of a full-length cDNA encoding human liver SAM-synthetase: tissue specific gene expression and mRNA levels in hepatopathies. Biochem Journal 1993; 293:481–486.
Pajares, M.A; Corrales,F; Ochoa,P; Mato,J.M. The role of cysteine 150 in the structure and activity of rat liver SAM-synthetase.Biochem.J 1991; 274:225–229.
Markham,G.D.; De Parasis J. Gatmaitan,J. The sequence of met K. the structural gene for S-adenosylmethionine synthetases in Sacchromyces cerevisae. J.Biol Chem. 1984; 259:14504– 14507.
Thomas,D.Surdin-Kerjan y.SAM I,the structural gene for one of the S-adenosylmethionine synthetases in Saccharomyces cerevisae. J.Biol:Chem.1987; 262:16704–16709.
Thomas D.Rothstein R.Rosenberg N.Surdin-Kerjan Y.SAM 2 encodes the second methionine S-adenosyl transferase in Saccharomyces cerevisae. Mol Cell Biol 1988; 8:5132–5139.
Pajares, M.A.; Corrales, F.; Durán, C.; Mato, J.M.; Alvarez, L.: How is rat liver S-adenosylmethionine synthetase regulated?. FEBS Letters 1992; 309:1–4.
Lieber, C; De Carlo, I.M.; Lowe, N.; Saraki, R.; Leo, M.A.: S-Adenosyl-L-Methionine attenuares alcohol-induced liver injury in the baboon. Hepatology 1990, 11:165–172.4.
Stramentinoli, G; Gualano, M; Ideo, G. Protective role of SAM on liver injury induced by D-galactosamine in rats. Biochem Pharmacol 1978; 27:1431–1433.
Corrales, F.; Giménez, A.; Alvarez, L.; Caballería, J.; Pajares, M.A.; Andreu, H.; Parés, A.; Mato,J.M.; Rodés, J.: S-adenosylmethionine treatment prevents carbon tetrachloride-induced S-adenosylmethionine synthetase inactivation and attenuates liver injury. Hepatology (1992), 16:1022–1027.
Brenner, D. A; Alcorn JM. Therapy for Hepatic fibrosis.Semin.Liver. Disease 1990; 10:74–83.
Ponsoda, X.; Jover, R.; Gómez-Lechón, M.J.; Fabra, R.; Trullenque, R.; Castell, J.V.: Intracellular glutathione in human hepatocytes incubated with SAMe and GSH-depleting drugs. Toxicology 1991, 70:293–302.
Vendemiale, G.; Altomare, E.; Trizio, T.; Le Grazie, C; Di Padova, C. et al.: S-adenosylmethionine on hepatic glutathione in patients with liver disease. Scand. J. Gastroenterol. 1989, 24:407–415.
Frezza,M.Surrenti,C.Manzillo G. Fiaccadori F.Bartolini M.Di Padova C. Oral S-adenosylmethionine in the symptomatic treatment of intrahepatic cholestasis: a double-blind, placebo controlled study. Gastroenterology 1990; 99:211–215.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer Science+Business Media New York
About this chapter
Cite this chapter
Mato, J.M., Alvarez, L., Ortiz, P., Mingorance, J., Durán, C., Pajares, M.A. (1994). S-Adenosyl-L-Methionine Synthetase and Methionine Metabolism Deficiencies in Cirrhosis. In: Felipo, V., Grisolia, S. (eds) Hepatic Encephalopathy, Hyperammonemia, and Ammonia Toxicity. Advances in Experimental Medicine and Biology, vol 368. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1989-8_11
Download citation
DOI: https://doi.org/10.1007/978-1-4615-1989-8_11
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5820-6
Online ISBN: 978-1-4615-1989-8
eBook Packages: Springer Book Archive